Local delivery of nitric oxide from an eluting stent to inhibit neointimal thickening in a porcine coronary injury model

Yonsei Medical Journal

Volumn 43, Issue 2, 2002, Pages 242-251

  Yoon, Junghan ^a   Wu, Chiung Jen ^b   Homme, James ^c   Tuch, Ronald J ^c   Wolff, Rodney G ^c   Topol, Eric J ^d   Michael Lincoff, A ^d  

^a Yonsei University Wonju   (South Korea)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c MEDTRONIC INC   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Angioplasty; Coronary artery disease; Nitric oxide; Restenosis

Indexed keywords

CYCLIC GMP; DEXAMETHASONE; FORSKOLIN; HEPARIN; METAL; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PACLITAXEL; POLYMER; POLYURETHAN; TANTALUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTERY WALL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY STENT; DEVICE; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; ELUTION; IN VITRO STUDY; IN VIVO STUDY; MORPHOMETRICS; NONHUMAN; RESTENOSIS; SWINE; TISSUE REPAIR;

EID: 0036247749     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2002.43.2.242     Document Type: Article

References (33)

1. Kinetics of drug delivery to the arterial wall via polyurethane-coated removable nitinol stent: Comparative study of two drugs
2. Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model
3. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
4. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation
5. Cyclic GMP mediates SIN-1-induced inhibition of human polymorphonuclear leukocytes
6. Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro
7. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells
8. Regulation of smooth muscle cell growth by endothelium-derived factors
9. Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells
10. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit
11. L-arginine inhibits neointimal formation following balloon injury
12. L-arginine inhibits balloon catheter-induced intimal hyperplasia
13. L-arginine improves endothelium-dependent vasorelaxation and reduces intimal hyperplasia after balloon angioplasty
14. Gene therapy inhibiting neointimal vascular lesion: In vivo transfer of endothelial cell nitric oxide synthetase gene
15. Persistent dysfunction of regenerated endothelium after balloon angioplasty of rabbit iliac artery
16. Differential recovery of prostacyclin and endothelium-derived relaxing factor after vascular injury
17. The antiplatelet effects of organic nitrates and related nitroso compounds in vitro and in vivo and their relevance to cardiovascular disorders
18. Generation of reactive oxygen species by the redox cycling of nitro-prusside
19. Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required
20. Spectrophotometric determination of famotidine in pharmaceutical preparations
21. Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model
22. Differential neointimal response to coronary artery injury in pigs and dogs. Implications for restenosis models
23. Subacute stent thrombosis and the anticoagulation controversy: Changes in drug therapy, operator technique, and the impact of intravascular ultrasound
24. Experimental study of thrombogenicity and foreign body reaction induced by heparin-coated coronary stents
25. Heparin coating of tantalum coronary stents reduces surface thrombin generation but not factor IXa generation
26. Localized arterial wall drug delivery from a polymer-coated removable metallic stent. Kinetics, distribution, and bioactivity of forskolin
27. Antiproliferative stent coatings: Taxol and related compounds
28. Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries
29. Biocompatibility of polymer-coated oversized metallic stents implanted in normal porcine coronary arteries
30. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries
31. Biocompatibility of polyurethane-coated stents: Tissue and vascular aspects
32. New methods of drug delivery
33. The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplasty